Thomas Vanwolleghem, MD PhD

Biography

Thomas Vanwolleghem is professor of Hepatology at the University of Antwerp, Faculty of Medicine and Health Sciences, Belgium, where leads the Viral Hepatitis Research Group. His main research focus is on virus-host interactions and the improvement of clinical outcomes in viral hepatitis infections. Apart from viral hepatitis, his clinical research interests focus on the diagnosis and treatment of portal hypertension, as co-PI of the Antwerp Hepatic Hemodynamic laboratory. He is a senior clinical researcher for the Research Fund of the Flemish government. He has authored more than 100 peer-reviewed papers, the majority on viral hepatitis, and is a frequent reviewer for scientific journals that focus on the study of viral hepatitis and liver diseases.
He is Deputy Head of the Department of Gastroenterology and Hepatology at the University Hospital Antwerp, where he coordinates the liver transplant program and the rare liver diseases outpatient clinic, as full member of the RARE-LIVER ERN.
He serves as the past-President of the Belgian Association for the Study of the Liver (BASL) and is Advisor of the Viral Hepatitis Prevention Board since 2019, a group of international experts dealing with topics on prevention and control of viral hepatitis.